Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CEL-SCI gets Israeli nod to commence phase III trial of multikine in head and neck cancer
pharmabiz
Saturday, April 2, 2011 - 11:15am
tags:
Cel-Sci, Multikine, head and neck cancer
Invida, Roche partner to commercialize primary care products
News-Medical.net
Saturday, April 2, 2011 - 11:10am
tags:
Invida, Roche
MethylGene Closing Private Placement
Stockhouse
Saturday, April 2, 2011 - 11:08am
tags:
MethylGene
Abbott: Battle Lost, War Won
Motley Fool
Saturday, April 2, 2011 - 10:30am
tags:
Abbott Laboratories, Norvir, GSK, lawsuits
Bristol-Myers Presents HCV Data
Yahoo/Zacks
Saturday, April 2, 2011 - 10:29am
tags:
Bristol-Myers Squibb, HCV, BMS-790052
Axiron® (Testosterone) Topical Solution CIII Now Available in Pharmacies
Yahoo/PR NewsWire
Saturday, April 2, 2011 - 10:28am
tags:
Axiron, testosterone, Eli Lilly
WPI to Launch a Bioequivalent Drug
Yahoo/Zacks
Saturday, April 2, 2011 - 10:27am
tags:
Watson Pharmaceuticals, Sanofi, anemia, Ferrlecit, Nulecit
Merck to Hold First-Quarter 2011 Sales and Earnings Conference Call on April 29
Yahoo/BusinessWire
Saturday, April 2, 2011 - 10:26am
tags:
Merck, earnings
Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson’s Disease to be Presented at the American Academy of Neurology Conference
Yahoo/BusinessWire
Saturday, April 2, 2011 - 10:25am
tags:
Impax, IPX066 APEX-PD, Parkinson's Disease
Positive Data for Vertex HCV Drug
Yahoo/Zacks
Saturday, April 2, 2011 - 10:23am
tags:
Vertex Pharmaceuticals, VX-222, HCV
Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011
Yahoo/BusinessWire
Saturday, April 2, 2011 - 10:22am
tags:
Idera Pharmaceuticals, IMO-2125, HCV
Gilead's Pact to Fight Cancer
Yahoo/Zacks
Saturday, April 2, 2011 - 10:20am
tags:
Eli Lilly, cancer
ViroPharma Drug Nears EU Approval
Investor's Business Daily
Saturday, April 2, 2011 - 10:19am
tags:
ViroPharma, angioedema, Cinryze
AVI BioPharma raising $30M; shares fall
bizjournals.com
Saturday, April 2, 2011 - 10:18am
tags:
AVI BioPharma
Medivation Shares Popped: What You Need to Know
Motley Fool
Saturday, April 2, 2011 - 10:17am
tags:
Medivation, MDV3100, prostate cancer
Acadia Pharma extends eye drug deal with Allergan
Yahoo/AP
Saturday, April 2, 2011 - 10:16am
tags:
Acadia, Allergan, glaucoma
Optimer Gets Boost From FDA
Minyanville
Saturday, April 2, 2011 - 10:14am
tags:
Optimer, fidaxomicin, Clostridium Difficile
Dendreon Remains Neutral
Yahoo/Zacks
Saturday, April 2, 2011 - 10:13am
tags:
Dendreon
Roche, Curis Drug Prevented Lesions, Reduced Tumor Size in Trial
Bloomberg
Friday, April 1, 2011 - 11:32am
tags:
Roche, Curis, skin cancer, vismodegib
KV Pharma Lowers Price Of Preemie Drug
Pharmalot
Friday, April 1, 2011 - 11:31am
tags:
KV Pharmaceutical, Makena, premature birth, drug pricing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.